Ex vivo gene therapy using targeted engraftment of NGF-expressing human NT2N neurons attenuates cognitive deficits following traumatic brain injury in mice.

MLA

Longhi, Luca, et al. “Ex Vivo Gene Therapy Using Targeted Engraftment of NGF-Expressing Human NT2N Neurons Attenuates Cognitive Deficits Following Traumatic Brain Injury in Mice.” Journal of Neurotrauma, vol. 21, no. 12, Dec. 2004, pp. 1723–36. EBSCOhost, https://doi.org/10.1089/neu.2004.21.1723.

APA

Longhi, L., Watson, D. J., Saatman, K. E., Thompson, H. J., Zhang, C., Fujimoto, S., Royo, N., Castelbuono, D., Raghupathi, R., Trojanowski, J. Q., Lee, V. M.-Y., Wolfe, J. H., Stocchetti, N., & McIntosh, T. K. (2004). Ex vivo gene therapy using targeted engraftment of NGF-expressing human NT2N neurons attenuates cognitive deficits following traumatic brain injury in mice. Journal of Neurotrauma, 21(12), 1723–1736. https://doi.org/10.1089/neu.2004.21.1723

Chicago

Longhi, Luca, Deborah J Watson, Kathryn E Saatman, Hilaire J Thompson, Chen Zhang, Scott Fujimoto, Nicolas Royo, et al. 2004. “Ex Vivo Gene Therapy Using Targeted Engraftment of NGF-Expressing Human NT2N Neurons Attenuates Cognitive Deficits Following Traumatic Brain Injury in Mice.” Journal of Neurotrauma 21 (12): 1723–36. doi:10.1089/neu.2004.21.1723.